Karnataka merges AYUSH drug authority with state FDA to streamline regulation
Aug 1, 2025


Source: Pharmabiz
Share:
The Karnataka government has issued an official order to merge the AYUSH Drug Licensing Authority, Drug Enforcement Division, and Drug Testing Laboratories with the State Food and Drug Administration (FDA). This move brings traditional medicine regulation under the same authority as modern drugs, aiming for seamless coordination and stricter oversight. States like Maharashtra, Gujarat, Goa, and Kerala have already adopted this model. Karnataka’s integration is expected to improve quality control, eliminate regulatory overlap, and boost credibility in both domestic and export markets.
Key highlights
Unified regulatory structure announced
All AYUSH-related functions now fall under the State FDA’s drug administration wing.
Modern and traditional drug licensing, enforcement, and testing will be centrally managed.
This shift aims to streamline approvals, renewals, and enforcement actions.
Testing labs consolidated for higher efficiency
Testing will move from AYUSH’s single lab to NABL-accredited FDA labs in Bengaluru, Hubballi, and Belagavi.
Unified testing protocols will ensure consistent quality standards.
The merger reduces duplication and expands lab access statewide.
Improved compliance and consumer safety
Centralized governance enables better monitoring of production plants and medicine outlets.
Regulatory delays are expected to decrease with one authority overseeing all decisions.
Analysts must now meet stricter qualifications under Section 33F of the Drugs & Cosmetics Act.
Following national model of drug regulation
Gujarat, Maharashtra, Goa, and Kerala have already integrated AYUSH into their FDA systems.
Karnataka joins this trend to unify drug governance and enhance public trust.
Export potential of AYUSH medicines may increase due to improved oversight.
By merging AYUSH regulation with the State FDA, Karnataka is reinforcing its commitment to quality, safety, and regulatory efficiency. The move reflects a growing nationwide trend to simplify drug control and enhance transparency across India’s pharma ecosystem — from herbal to allopathic.
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved


Source: Pharmabiz
The Karnataka government has issued an official order to merge the AYUSH Drug Licensing Authority, Drug Enforcement Division, and Drug Testing Laboratories with the State Food and Drug Administration (FDA). This move brings traditional medicine regulation under the same authority as modern drugs, aiming for seamless coordination and stricter oversight. States like Maharashtra, Gujarat, Goa, and Kerala have already adopted this model. Karnataka’s integration is expected to improve quality control, eliminate regulatory overlap, and boost credibility in both domestic and export markets.
Key highlights
Unified regulatory structure announced
All AYUSH-related functions now fall under the State FDA’s drug administration wing.
Modern and traditional drug licensing, enforcement, and testing will be centrally managed.
This shift aims to streamline approvals, renewals, and enforcement actions.
Testing labs consolidated for higher efficiency
Testing will move from AYUSH’s single lab to NABL-accredited FDA labs in Bengaluru, Hubballi, and Belagavi.
Unified testing protocols will ensure consistent quality standards.
The merger reduces duplication and expands lab access statewide.
Improved compliance and consumer safety
Centralized governance enables better monitoring of production plants and medicine outlets.
Regulatory delays are expected to decrease with one authority overseeing all decisions.
Analysts must now meet stricter qualifications under Section 33F of the Drugs & Cosmetics Act.
Following national model of drug regulation
Gujarat, Maharashtra, Goa, and Kerala have already integrated AYUSH into their FDA systems.
Karnataka joins this trend to unify drug governance and enhance public trust.
Export potential of AYUSH medicines may increase due to improved oversight.
By merging AYUSH regulation with the State FDA, Karnataka is reinforcing its commitment to quality, safety, and regulatory efficiency. The move reflects a growing nationwide trend to simplify drug control and enhance transparency across India’s pharma ecosystem — from herbal to allopathic.
Share:
Read Next
Read Next
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved